AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 8732321 — intervention group
Group type: EXPERIMENTAL
Intervention: Results of a self‐administered computerized assessment (PROQSY) of common mental disorders provided to the GP
Number of subjects: 681
Study 8732321 — intervention group
Group type: COMPARATOR
Intervention: Results of the 12 item General Health Questionnaire (GHQ) provided to the GP
Number of subjects: 681
Study 8732321 — intervention group
Group type: COMPARATOR
Intervention: No additional information given to the GP
Number of subjects: 681
Study 1890863 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous bone marrow transplantation following high dose chemotherapy and radiation therapy (RT)
Number of subjects: 0
Study 1890863 — intervention group
Group type: EXPERIMENTAL
Intervention: RT followed by adjuvant chemotherapy
Number of subjects: 0
Study 1890863 — intervention group
Group type: COMPARATOR
Intervention: RT alone
Number of subjects: 0
Study 6579843 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide (intranasal corticosteroid)
Number of subjects: 37
Study 6579843 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study 30556961 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical 0.1% triamcinolone (TA) preparation
Number of subjects: 40
Study 30556961 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical 0.2% hyaluronic acid (HA) preparation
Number of subjects: 40
Study 27825036 — intervention group
Group type: EXPERIMENTAL
Intervention: MAPS+ (Motivation And Problem Solving Plus)
Number of subjects: 202
Study 27825036 — intervention group
Group type: COMPARATOR
Intervention: S-MAPS (Standard MAPS treatment)
Number of subjects: 202
Study 25369831 — intervention group
Group type: EXPERIMENTAL
Intervention: Rimostil (50 mg)
Number of subjects: 0
Study 25369831 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 23722649 — intervention group
Group type: EXPERIMENTAL
Intervention: Zotarolimus-eluting stents (ZES)
Number of subjects: 60
Study 23722649 — intervention group
Group type: COMPARATOR
Intervention: Everolimus-eluting stents (EES)
Number of subjects: 60
Study 20371736 — intervention group
Group type: EXPERIMENTAL
Intervention: Linezolid with rifampin
Number of subjects: 16
Study 20371736 — intervention group
Group type: COMPARATOR
Intervention: Linezolid alone
Number of subjects: 16
Study 20371736 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifampin
Number of subjects: 16
Study 20371736 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoconazole
Number of subjects: 16
Study 20371736 — intervention group
Group type: EXPERIMENTAL
Intervention: Linezolid and rifampin (combination)
Number of subjects: 16
Study 19738292 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle training without electrical stimulation
Number of subjects: 24
Study 19738292 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle training with electrical stimulation
Number of subjects: 24
Study 16937509 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined indwelling catheter celiac drainage and intra-abdominal pressure monitoring, routine conservative measures (group 1)
Number of subjects: 0
Study 16937509 — intervention group
Group type: COMPARATOR
Intervention: Routine non-operative conservative treatments (group 2)
Number of subjects: 0
Study 16937509 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined indwelling catheter celiac drainage and intra-abdominal pressure monitoring (group 1)
Number of subjects: 0
Study 14618331 — intervention group
Group type: EXPERIMENTAL
Intervention: Isokinetic weight training three times per week for 12 weeks
Number of subjects: 45
Study 14618331 — intervention group
Group type: COMPARATOR
Intervention: Strength training for 2, 4, or 6 weeks prior to cycle ergometry
Number of subjects: 45
Study 14618331 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent weight training during FES cycle ergometry three times per week
Number of subjects: 45
Study 11737179 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane-nitrous oxide anaesthesia
Number of subjects: 45
Study 11737179 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostaglandin E1 infusion
Number of subjects: 45
Study 11737179 — intervention group
Group type: COMPARATOR
Intervention: Control group (no hypotensive agent)
Number of subjects: 45
Study 9224079 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group consuming eight servings of fruit and vegetables a day
Number of subjects: 87
Study 9224079 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 87
Study 7957150 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance exercise at 85% of IAT (E85)
Number of subjects: 14
Study 7957150 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance exercise at 95% of IAT (E95)
Number of subjects: 14
Study 7957150 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance exercise at 100% of IAT (E100)
Number of subjects: 14
Study 7957150 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance exercise at 105% of IAT (E105)
Number of subjects: 14
Study 7957150 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance exercises at or below IAT (E85-E100)
Number of subjects: 14
Study 3591681 — intervention group
Group type: EXPERIMENTAL
Intervention: Pindolol (mean dose 17 +/- 8 mg/day)
Number of subjects: 11
Study 3591681 — intervention group
Group type: COMPARATOR
Intervention: Propranolol (130 +/- 40 mg/day)
Number of subjects: 11
Study 30952118 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep brain stimulation (DBS) in the LQ study
Number of subjects: 69
Study 30952118 — intervention group
Group type: COMPARATOR
Intervention: Deep brain stimulation (DBS) in the VA/NINDS trial
Number of subjects: 69
Study 30952118 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep brain stimulation (DBS) in the LQ study among levodopa full responders
Number of subjects: 69
Study 30952118 — intervention group
Group type: COMPARATOR
Intervention: Deep brain stimulation (DBS) in the VA/NINDS trial among levodopa full responders
Number of subjects: 69
Study 28958804 — intervention group
Group type: EXPERIMENTAL
Intervention: Low glycemic index (LGI) diet
Number of subjects: 201
Study 28958804 — intervention group
Group type: COMPARATOR
Intervention: High-cereal fibre diet
Number of subjects: 201
Study 27442394 — intervention group
Group type: EXPERIMENTAL
Intervention: GA + TAP-D block with 25 ml of 0.5% ropivacaine + 4 mg Dexamethasone
Number of subjects: 90
Study 27442394 — intervention group
Group type: EXPERIMENTAL
Intervention: GA + TAP block with 25 ml of 0.5% ropivacaine
Number of subjects: 90
Study 27442394 — intervention group
Group type: COMPARATOR
Intervention: GA
Number of subjects: 90
Study 22987794 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical Activity (PA)
Number of subjects: 424
Study 22987794 — intervention group
Group type: COMPARATOR
Intervention: Successful Aging (SA) education program
Number of subjects: 424
Study 21998477 — intervention group
Group type: EXPERIMENTAL
Intervention: Live attenuated vaccine
Number of subjects: 0
Study 21998477 — intervention group
Group type: EXPERIMENTAL
Intervention: Inactivated vaccine
Number of subjects: 0
Study 21998477 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 18438931 — intervention group
Group type: EXPERIMENTAL
Intervention: Medial insole (insoles with 8‐mm medial elevation at the rearfoot, n = 16)
Number of subjects: 30
Study 18438931 — intervention group
Group type: COMPARATOR
Intervention: Neutral insole (similar insole without elevation, n = 14)
Number of subjects: 30
Study 17069958 — intervention group
Group type: EXPERIMENTAL
Intervention: Compression: ventilation ratio 15:2
Number of subjects: 68
Study 17069958 — intervention group
Group type: EXPERIMENTAL
Intervention: Compression: ventilation ratio 30:2
Number of subjects: 68
Study 17069958 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous chest compressions without ventilations
Number of subjects: 68
Study 15452808 — intervention group
Group type: EXPERIMENTAL
Intervention: Demineralized bone powder (DBP)
Number of subjects: 24
Study 15452808 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided-tissue regeneration therapy (GTR therapy)
Number of subjects: 24
Study 15452808 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 24
Study 11605925 — intervention group
Group type: EXPERIMENTAL
Intervention: QoR-40 (quality of recovery score) on days 1-3 and 1 month after surgery
Number of subjects: 120
Study 11605925 — intervention group
Group type: EXPERIMENTAL
Intervention: SF-36 (short-form health survey) at 1 and 3 months after surgery
Number of subjects: 120
Study 11605925 — intervention group
Group type: EXPERIMENTAL
Intervention: QoR-40 on day 3
Number of subjects: 120
Study 11605925 — intervention group
Group type: EXPERIMENTAL
Intervention: Poor-quality recovery in hospital
Number of subjects: 120
Study 9699821 — intervention group
Group type: EXPERIMENTAL
Intervention: Cemented TKR
Number of subjects: 110
Study 9699821 — intervention group
Group type: EXPERIMENTAL
Intervention: Uncemented TKR
Number of subjects: 110
Study 9699821 — intervention group
Group type: COMPARATOR
Intervention: Cemented THR
Number of subjects: 110
Study 8007587 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous ambulatory peritoneal dialysis (CAPD)
Number of subjects: 4136
Study 12283017 — intervention group
Group type: EXPERIMENTAL
Intervention: SED-S (sucrose-free semi-elemental diet)
Number of subjects: 74
Study 12283017 — intervention group
Group type: COMPARATOR
Intervention: Cow's milk
Number of subjects: 74
Study 12283017 — intervention group
Group type: EXPERIMENTAL
Intervention: SED+S (sucrose-containing semi-elemental diet)
Number of subjects: 74
Study 31635898 — intervention group
Group type: EXPERIMENTAL
Intervention: Clarithromycin (CAM) and glucocorticoid (DEX)
Number of subjects: 0
Study 31635898 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (DEX) and Clarithromycin (CAM)
Number of subjects: 0
Study 31635898 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 0
Study 31635898 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-17A and IL-6
Number of subjects: 0
Study 28128977 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored Intervention (TI)
Number of subjects: 118
Study 28128977 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 118
Study 27183373 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound
Number of subjects: 110
Study 27183373 — intervention group
Group type: COMPARATOR
Intervention: Palpation
Number of subjects: 110
Study 25428435 — intervention group
Group type: EXPERIMENTAL
Intervention: Supernatant embryo culture fluid (SEET)
Number of subjects: 60
Study 23204168 — intervention group
Group type: EXPERIMENTAL
Intervention: FMP2.1/AS02(A) malaria vaccine
Number of subjects: 0
Study 23204168 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 21820244 — intervention group
Group type: EXPERIMENTAL
Intervention: DVD plus information booklet (n=57)
Number of subjects: 108
Study 21820244 — intervention group
Group type: COMPARATOR
Intervention: Booklet only (n=51)
Number of subjects: 108
Study 19694381 — intervention group
Group type: COMPARATOR
Intervention: Tamsulosin (0.2 mg once a day)
Number of subjects: 53
Study 19694381 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamsulosin (0.2 mg once a day) + Tolterodine (2 mg twice a day)
Number of subjects: 53
Study 16476220 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term insulin treatment
Number of subjects: 0
Study 16476220 — intervention group
Group type: COMPARATOR
Intervention: Conventional management
Number of subjects: 0
Study 16476220 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose control
Number of subjects: 0
Study 15470173 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane 1 MAC, administered 30 min prior to the end of the surgical procedure.
Number of subjects: 30
Study 15470173 — intervention group
Group type: COMPARATOR
Intervention: Propofol (control group).
Number of subjects: 30
Study 11304776 — intervention group
Group type: EXPERIMENTAL
Intervention: Epirubicin (110 mg/m²) followed by paclitaxel (225 mg/m²) every 2 weeks for four cycles each, with granulocyte colony-stimulating factor support (Group A)
Number of subjects: 183
Study 11304776 — intervention group
Group type: COMPARATOR
Intervention: Epirubicin (80 mg/m²) followed by paclitaxel (175 mg/m²) every 3 weeks for six cycles (Group B)
Number of subjects: 183
Study 9103390 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with gynecological cancers
Number of subjects: 220
Study 9103390 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy women)
Number of subjects: 220
Study 9103390 — intervention group
Group type: COMPARATOR
Intervention: General public (healthy women)
Number of subjects: 220
Study 9103390 — intervention group
Group type: EXPERIMENTAL
Intervention: Formal education
Number of subjects: 220
Study 7506170 — intervention group
Group type: EXPERIMENTAL
Intervention: nimesulide (100mg twice daily)
Number of subjects: 50
Study 7506170 — intervention group
Group type: COMPARATOR
Intervention: diclofenac (50mg twice daily)
Number of subjects: 50
Study 3318259 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin + glipizide (3 X 10 mg/day)
Number of subjects: 10
Study 3318259 — intervention group
Group type: COMPARATOR
Intervention: Insulin alone
Number of subjects: 10
Study 31973765 — intervention group
Group type: EXPERIMENTAL
Intervention: Communication skills training for physicians (3 sessions of Focus-Group Discussion and 2 workshops)
Number of subjects: 240
Study 31973765 — intervention group
Group type: COMPARATOR
Intervention: Routine care (Control group)
Number of subjects: 240
Study 29402848 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 10 mg
Number of subjects: 106
Study 29402848 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 20 mg
Number of subjects: 106
Study 29402848 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosuvastatin 10 mg
Number of subjects: 106
Study 29402848 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosuvastatin 20 mg
Number of subjects: 106
Study 29402848 — intervention group
Group type: COMPARATOR
Intervention: Control (lifestyle changes only)
Number of subjects: 106
Study 26259808 — intervention group
Group type: EXPERIMENTAL
Intervention: labetalol (less tight control)
Number of subjects: 987
Study 26259808 — intervention group
Group type: EXPERIMENTAL
Intervention: labetalol (tight control)
Number of subjects: 987
Study 26259808 — intervention group
Group type: EXPERIMENTAL
Intervention: methyldopa (less tight control)
Number of subjects: 987
Study 26259808 — intervention group
Group type: EXPERIMENTAL
Intervention: methyldopa (tight control)
Number of subjects: 987
Study 25199613 — intervention group
Group type: EXPERIMENTAL
Intervention: GCS scoring aid
Number of subjects: 178
Study 25199613 — intervention group
Group type: COMPARATOR
Intervention: No GCS scoring aid
Number of subjects: 178
Study 25199613 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall accuracy
Number of subjects: 178
Study 25199613 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcomponent accuracy
Number of subjects: 178
Study 22571553 — intervention group
Group type: EXPERIMENTAL
Intervention: Social support and social network characteristics
Number of subjects: 151
Study 22571553 — intervention group
Group type: EXPERIMENTAL
Intervention: Number of smokers in the social network
Number of subjects: 151
Study 22571553 — intervention group
Group type: EXPERIMENTAL
Intervention: Partner smoking
Number of subjects: 151
Study 20575195 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-ligating (SL) porcelain brackets on anterior teeth and SL metal brackets on posterior teeth
Number of subjects: 60
Study 20575195 — intervention group
Group type: COMPARATOR
Intervention: Conventional porcelain (CP) brackets tied with ligatures on anterior teeth and conventional metal brackets on posterior teeth
Number of subjects: 60
Study 19047916 — intervention group
Group type: EXPERIMENTAL
Intervention: Prenatal drug exposure (PDE) children remaining in maternal care
Number of subjects: 144
Study 19047916 — intervention group
Group type: EXPERIMENTAL
Intervention: Prenatal drug exposure (PDE) children in nonmaternal care
Number of subjects: 144
Study 19047916 — intervention group
Group type: COMPARATOR
Intervention: Community comparison (CC) children
Number of subjects: 144
Study 19047916 — intervention group
Group type: EXPERIMENTAL
Intervention: CPT errors of omission and commission
Number of subjects: 144
Study 16178830 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-directed learning (computer-assisted)
Number of subjects: 175
Study 14578832 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose midazolam (1 mg/kg, HDM)
Number of subjects: 65
Study 14578832 — intervention group
Group type: COMPARATOR
Intervention: Standard-dose midazolam (0.5 mg/kg, SDM)
Number of subjects: 65
Study 11051305 — intervention group
Group type: COMPARATOR
Intervention: Simulated altitude of 0 m
Number of subjects: 4
Study 11051305 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulated altitude of 1200 m
Number of subjects: 4
Study 11051305 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulated altitude of 2400 m
Number of subjects: 4
Study 11051305 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulated altitude of 3700 m
Number of subjects: 4
Study 8840841 — intervention group
Group type: EXPERIMENTAL
Intervention: Ambulatory ECG (AECG) monitoring
Number of subjects: 910
Study 8840841 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise treadmill test (ETT)
Number of subjects: 910
Study 8840841 — intervention group
Group type: COMPARATOR
Intervention: Correlation between ETT and AECG
Number of subjects: 910
Study 1371225 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser grid photocoagulation for retinal pigment epithelial detachment
Number of subjects: 0
Study 1371225 — intervention group
Group type: COMPARATOR
Intervention: Untreated lesions (control group)
Number of subjects: 0
Study 6570116 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefoxitin (2 g) intravenously at the time of induction of anaesthesia
Number of subjects: 60
Study 6570116 — intervention group
Group type: COMPARATOR
Intervention: Control group without the antibiotic
Number of subjects: 60
Study 29282989 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic companion robot (PARO)
Number of subjects: 5
Study 29282989 — intervention group
Group type: COMPARATOR
Intervention: Look-alike plush toy and usual care
Number of subjects: 5
Study 30205746 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 267
Study 30205746 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 mg BMS-986165 every other day
Number of subjects: 267
Study 30205746 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 mg BMS-986165 daily
Number of subjects: 267
Study 30205746 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 mg BMS-986165 twice daily
Number of subjects: 267
Study 30205746 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 mg BMS-986165 twice daily
Number of subjects: 267
Study 30205746 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 mg BMS-986165 daily
Number of subjects: 267
Study 27454263 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen 50 mg
Number of subjects: 90
Study 27454263 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydromorphone 0.25 mg
Number of subjects: 90
Study 27454263 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen 25 mg + Hydromorphone 0.125 mg
Number of subjects: 90
Study 27454263 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen and Hydromorphone combination
Number of subjects: 90
Study 24599110 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive glycaemic control (INT)
Number of subjects: 858
Study 24599110 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline C-peptide
Number of subjects: 858
Study 24599110 — intervention group
Group type: EXPERIMENTAL
Intervention: Poor glucose control at baseline
Number of subjects: 858
Study 22043837 — intervention group
Group type: EXPERIMENTAL
Intervention: Integration of HIV care services including HAART into ANC clinics
Number of subjects: 36
Study 21194605 — intervention group
Group type: COMPARATOR
Intervention: Levetiracetam 250 mg administered as an immediate-release tablet
Number of subjects: 9
Study 21194605 — intervention group
Group type: EXPERIMENTAL
Intervention: Levetiracetam delivered in the proximal small bowel
Number of subjects: 9
Study 21194605 — intervention group
Group type: EXPERIMENTAL
Intervention: Levetiracetam delivered in the distal small bowel
Number of subjects: 9
Study 21194605 — intervention group
Group type: EXPERIMENTAL
Intervention: Levetiracetam delivered in the ascending colon
Number of subjects: 9
Study 17497175 — intervention group
Group type: EXPERIMENTAL
Intervention: COMT Ex4‐76C > G (Leu136Leu) polymorphism
Number of subjects: 2371
Study 17497175 — intervention group
Group type: EXPERIMENTAL
Intervention: COMT haplotypes including variant allele for COMT Ex4‐76 C > G
Number of subjects: 2371
Study 17497175 — intervention group
Group type: EXPERIMENTAL
Intervention: COMT polymorphisms
Number of subjects: 2371
Study 16220801 — intervention group
Group type: EXPERIMENTAL
Intervention: Water‐activated zinc polycarboxylate cement with 0.12% chlorhexidine gluconate
Number of subjects: 9
Study 16220801 — intervention group
Group type: COMPARATOR
Intervention: Water‐activated zinc polycarboxylate cement (control group)
Number of subjects: 9
Study 12118903 — intervention group
Group type: EXPERIMENTAL
Intervention: Darusentan 10 mg
Number of subjects: 392
Study 12118903 — intervention group
Group type: EXPERIMENTAL
Intervention: Darusentan 30 mg
Number of subjects: 392
Study 12118903 — intervention group
Group type: EXPERIMENTAL
Intervention: Darusentan 100 mg
Number of subjects: 392
Study 12118903 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 392
Study 11332870 — intervention group
Group type: EXPERIMENTAL
Intervention: Piracetam treatment
Number of subjects: 24
Study 11332870 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 24
Study 9071195 — intervention group
Group type: EXPERIMENTAL
Intervention: Isradipine
Number of subjects: 24
Study 9071195 — intervention group
Group type: COMPARATOR
Intervention: Atenolol
Number of subjects: 24
Study 9071195 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 9071195 — intervention group
Group type: COMPARATOR
Intervention: Nondiabetic controls
Number of subjects: 24
Study 9071195 — intervention group
Group type: EXPERIMENTAL
Intervention: Isradipine and Atenolol
Number of subjects: 24
Study 8201928 — intervention group
Group type: EXPERIMENTAL
Intervention: Norfloxacin 800 mg daily or Ciprofloxacin 1000 mg daily
Number of subjects: 14
Study 3493903 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose MTX (regimen I)
Number of subjects: 106